Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003464767 | SCV004207601 | pathogenic | SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN | 2023-06-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004741502 | SCV005364069 | likely pathogenic | TYR-related disorder | 2024-07-30 | no assertion criteria provided | clinical testing | The TYR c.1184G>A variant is predicted to result in the amino acid substitution p.Ser395Asn. This variant has been reported in the compound heterozygous state in individuals with oculocutaneous albinism (Spritz et al. 1997. PubMed ID: 9259202; Table S1, Wei et al. 2021. PubMed ID: 34838614). This variant is predicted to have a damaging effect on the protein. This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Given the evidence, we interpret this variant as likely pathogenic. |